Bank of New York Mellon’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,110
| Closed | -$9.71K | – | 4379 |
|
|
2023
Q2 | $9.71K | Sell |
2,110
-1,045
| -33% | -$4.81K | ﹤0.01% | 4332 |
|
|
2023
Q1 | $22.4K | Hold |
3,155
| – | – | ﹤0.01% | 4294 |
|
|
2022
Q4 | $20.3K | Sell |
3,155
-9
| -0.3% | -$58 | ﹤0.01% | 4354 |
|
|
2022
Q3 | $46K | Hold |
3,164
| – | – | ﹤0.01% | 4336 |
|
|
2022
Q2 | $57K | Sell |
3,164
-7,491
| -70% | -$135K | ﹤0.01% | 4325 |
|
|
2022
Q1 | $317K | Sell |
10,655
-75
| -0.7% | -$2.23K | ﹤0.01% | 3984 |
|
|
2021
Q4 | $466K | Buy |
10,730
+167
| +2% | +$7.25K | ﹤0.01% | 3854 |
|
|
2021
Q3 | $752K | Buy |
10,563
+779
| +8% | +$55.5K | ﹤0.01% | 3565 |
|
|
2021
Q2 | $1.12M | Buy |
9,784
+609
| +7% | +$69.9K | ﹤0.01% | 3331 |
|
|
2021
Q1 | $953K | Buy |
9,175
+806
| +10% | +$83.7K | ﹤0.01% | 3357 |
|
|
2020
Q4 | $400K | Buy |
8,369
+2,494
| +42% | +$119K | ﹤0.01% | 3720 |
|
|
2020
Q3 | $163K | Hold |
5,875
| – | – | ﹤0.01% | 3885 |
|
|
2020
Q2 | $224K | Buy |
5,875
+2,483
| +73% | +$94.7K | ﹤0.01% | 3766 |
|
|
2020
Q1 | $167K | Buy |
3,392
+675
| +25% | +$33.2K | ﹤0.01% | 3785 |
|
|
2019
Q4 | $122K | Hold |
2,717
| – | – | ﹤0.01% | 3995 |
|
|
2019
Q3 | $114K | Sell |
2,717
-1,169
| -30% | -$49K | ﹤0.01% | 3994 |
|
|
2019
Q2 | $194K | Buy |
3,886
+2,912
| +299% | +$145K | ﹤0.01% | 3923 |
|
|
2019
Q1 | $77K | Buy |
+974
| New | +$77K | ﹤0.01% | 4032 |
|
|
2018
Q1 | – | Sell |
-839
| Closed | -$78K | – | 4367 |
|
|
2017
Q4 | $78K | Sell |
839
-14
| -2% | -$1.3K | ﹤0.01% | 4122 |
|
|
2017
Q3 | $129K | Sell |
853
-1
| -0.1% | -$151 | ﹤0.01% | 3961 |
|
|
2017
Q2 | $89K | Buy |
854
+325
| +61% | +$33.9K | ﹤0.01% | 4048 |
|
|
2017
Q1 | $63K | Buy |
+529
| New | +$63K | ﹤0.01% | 4106 |
|